Abstract
The resistance of infectious bacteria to current antibiotics is a worldwide problem. Previous studies have demonstrated the efficacy of nanostructured molecules against pathogens as an innovative methodology for the development of novel drugs. Currently, 95% of properties limited pharmacies applicability such as low solubility, short half-life in the circulatory system, toxicity associated to controlled release and immunogenicity. Furthermore, nanobiotechnology provides a different perspective for modifying these properties and allows innovative drug development. In this context, this review aims to describe different methods, polymers, and drugs used to obtain and analyze nanostructures associated with antibiotics as an unconventional and innovative tool for bacterial control. Biotechnology provides a different perspective for modifying drug properties and allows innovative drug development. This review describes nanostructures in association with antibiotics as an unconventional and innovative tool for bacterial control.
Keywords: Antibiotics, bacteria, nanoparticles, antimicrobial peptides, infectious diseases
Current Medicinal Chemistry
Title:Nanoformulated Antibiotics: the Next Step for Pathogenic Bacteria Control
Volume: 20 Issue: 10
Author(s): Amanda Caroline Marques Saude, Mariana Dornelles Cherobim, Andre Correa Amaral, Simoni Campos Dias and Octavio Luiz Franco
Affiliation:
Keywords: Antibiotics, bacteria, nanoparticles, antimicrobial peptides, infectious diseases
Abstract: The resistance of infectious bacteria to current antibiotics is a worldwide problem. Previous studies have demonstrated the efficacy of nanostructured molecules against pathogens as an innovative methodology for the development of novel drugs. Currently, 95% of properties limited pharmacies applicability such as low solubility, short half-life in the circulatory system, toxicity associated to controlled release and immunogenicity. Furthermore, nanobiotechnology provides a different perspective for modifying these properties and allows innovative drug development. In this context, this review aims to describe different methods, polymers, and drugs used to obtain and analyze nanostructures associated with antibiotics as an unconventional and innovative tool for bacterial control. Biotechnology provides a different perspective for modifying drug properties and allows innovative drug development. This review describes nanostructures in association with antibiotics as an unconventional and innovative tool for bacterial control.
Export Options
About this article
Cite this article as:
Caroline Marques Saude Amanda, Dornelles Cherobim Mariana, Correa Amaral Andre, Campos Dias Simoni and Luiz Franco Octavio, Nanoformulated Antibiotics: the Next Step for Pathogenic Bacteria Control, Current Medicinal Chemistry 2013; 20 (10) . https://dx.doi.org/10.2174/0929867311320100004
DOI https://dx.doi.org/10.2174/0929867311320100004 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Past, Recent Progresses and Future Perspectives of Nanotechnology Applied to Antifungal Agents
Current Drug Metabolism 5-HT1 Receptors
Current Drug Targets - CNS & Neurological Disorders Microbes, Immunity and Multiple Sclerosis: An Update
Current Immunology Reviews (Discontinued) Beyond Hemostasis: The Role of Platelets in Inflammation, Malignancy and Infection
Cardiovascular & Hematological Disorders-Drug Targets Sulfonamides: Antiviral Strategy for Neglected Tropical Disease Virus
Current Organic Chemistry Exposure to Perinatal Infections and Bipolar Disorder: A Systematic Review
Current Molecular Medicine Innate Immune Surveillance in the Central Nervous System Following Legionella pneumophila Infection
CNS & Neurological Disorders - Drug Targets Characterization and antiherpetic activity of native and chemically sulfated polysaccharide from <i>Adenanthera pavonina</i>
Current Pharmaceutical Biotechnology Bone Marrow Mesenchymal Stem Cells: Agents of Immunomodulation and Neuroprotection
Current Stem Cell Research & Therapy Mixed Connective Tissue Disease (MCTD) – A Coming of Age
Current Rheumatology Reviews Clonal Expansion of Mitochondrial DNA Deletions and the Progression of Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets Heat Shock Proteins And Neuroprotection
Recent Patents on DNA & Gene Sequences Disease-Induced Neuroinflammation and Depression
CNS & Neurological Disorders - Drug Targets Invasive Aspergillosis: Focus on New Approaches and New Therapeutic Agents
Current Medicinal Chemistry - Anti-Infective Agents Radiation and Gene Therapy: Rays of Hope for the New Millennium?
Current Gene Therapy Cytomegalovirus Infections in Non-Immunocompromised and Immunocompromised Patients in the Intensive Care Unit
Infectious Disorders - Drug Targets History and Milestones of Mouse Models of Autoimmune Diseases
Current Pharmaceutical Design The Causative Organisms of Bacterial Meningitis and their Antimicrobial Resistance Profiles in Iranian Children in 2011-2016
Infectious Disorders - Drug Targets Vasopressin in Health and Disease with a Focus on Affective Disorders
Central Nervous System Agents in Medicinal Chemistry The Challenge of Counterfeit Drugs: A Comprehensive Review on Prevalence, Detection and Preventive Measures
Current Drug Safety